Full-stack gut wellness brand Lifechart raises $500,000 in funding led by Prajay Advisors LLP

Homegrown full-stack gut wellness brand Lifechart has raised $500,000 in the latest funding round led by Prajay Advisors LLP and various other investors.

The $500,000 raised in this round saw a $250,000 investment from Prajay Advisors LLP, with Cignas from NA Shah Advisors LLP serving as the transaction advisor.

The remaining amount was secured through contributions from Agility Ventures, Expert Dojo, and several angel investors, including Ahana Gautam, Nitish Mittersain (Founder of Nazara Technologies Pvt. Ltd.), Sarath Sura (Founder of Sunn91 Ventures), and Marwari Angels.

Notably, the investments were made using convertible instruments, which were converted into equity in this round.

In addition, Lifechart had previously secured $200,000 in a pre-seed round from Expert Dojo and Nitish Mittersain in 2022. 

Focus on AI and product development

With this new investment, Lifechart aims to enhance its AI-driven diagnostic capabilities, launch new proprietary solutions, and build a dedicated brand targeting tier-1 cities.

The startup is focused on addressing India’s growing gut health issues by offering products and solutions crafted by doctors from BAMS (Bachelor of Ayurvedic Medicine and Surgery) and BHMS (Bachelor of Homeopathic Medicine and Surgery).

These offerings include plant-based microbiome-focused products and wellness kits aimed at common gut ailments like constipation, fatty liver, piles, gas, and acidity.

"We are proud to have attracted the trust of marquee investors, especially during a funding winter. The new capital will be used to enhance our AI capabilities, launch our proprietary diagnostic solutions, and build a new brand targeting Tier 1 cities," said Mukul Shah, CEO and Co-founder of Lifechart.

Expansion plans and market potential

Lifechart is leveraging its technology and expertise to reach underserved regions in India. The startup claims to have impacted over 250,000 customers, primarily from tier II, III, and IV cities.

To cater to the growing demand, the startup is hiring 50 in-house BAMS and BHMS doctors, further enhancing its capacity to deliver effective solutions.

It is also developing India’s first gut wellness clinics and supermarkets, with plans to open 150 clinics over the next three years.

The initiative aims to create a robust infrastructure for gut health diagnostics and treatment across both urban and rural areas.

 "Our vision is not just to sell products but to focus on diagnosing and treating gut health issues, which is a critical unmet need in India. This is what sets us apart from competitors," Shah added.

Planning to raise additional funding

Currently, Lifechart is in talks to raise an additional $1–$2 million through inbound interest from a venture capital firm based in Delhi NCR. The startup aims to use these funds to expand its full-stack model further and grow its presence in tier-1 cities with its new product line and clinic expansions.

Industry reports estimate that the global gut health market could reach $18 billion by 2025–26. With its comprehensive diagnostic and treatment solutions, Lifechart is positioning itself to capture a significant share of this expanding market.

Prakash Mody (Founder of Unichem Laboratory) and Jayendra Shah, Founders of Prajay LLP said in a joint statement that “Gut health is a growing concern not only in India but throughout the world. We are quite excited the way Lifechart with its unique technology & fullstack approach is solving this huge problem. We have full confidence in Mukul’s vision & execution abilities as he has been a serial entrepreneur in the past &  has successfully  built  YoloBus (India’s leading Intercity Bus platform) & got it successfully acquired.”